ATLASEvogene (EVGN) earnings date: Nov 19, 2026
Evogene (EVGN) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 19, 2026, before the open. Analysts expect EPS of -$0.19.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on EVGN
| Last price | $0.37 (-2.6%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.1% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Evogene stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Evogene reports on Nov 19, 2026. One email the day before, with ATLAS’s read on Evogene. You can switch it off at any time.
Alert me before EVGN reportsFree to start. Creating an account takes under a minute.
Notify me when Evogene reports
Track EVGN free Add Evogene to a free ATLAS watchlist and see its next report date in one place.
EVGN earnings at a glance
| Next report (confirmed) | Thu, Nov 19, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.19 |
| Last report | Aug 18, 2026 · Beat |
| Beat rate (last 5 reports) | 2 of 5 (40%) |
| Average EPS surprise | -40.8% |
| Average move around a report | ±6.8% (last 5) |
| Sector | Healthcare · Biotechnology |
Evogene earnings history: last 5 reports
Evogene last reported on Aug 18, 2026: EPS of -$0.13 against an estimate of -$0.27 (+51.8% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 18, 2026 | -$0.27 | -$0.13 | +51.8% | Beat | +7.1% |
| May 20, 2026 | -$0.27 | -$0.61 | -125.9% | Miss | -6.8% |
| Mar 5, 2026 | -$0.26 | -$0.62 | -138.5% | Miss | -8.3% |
| Nov 20, 2025 | -$0.41 | -$0.46 | -12.2% | Miss | -3.4% |
| Aug 19, 2025 | -$0.63 | -$0.50 | +20.6% | Beat | -8.3% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for EVGN
See the fair value, the probability range and the earnings history of Evogene on its ATLAS page.
Evogene (EVGN) stock analysisPlans from €3.99 a month.
Evogene earnings: frequently asked questions
When does Evogene (EVGN) report earnings?
Evogene is scheduled to report on Thursday, November 19, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for EVGN?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.19 per share (USD). Estimates can change before the report.
How often does EVGN beat earnings estimates?
Of its last 5 reports with a recorded result, Evogene beat the EPS estimate 2 times; the average surprise was -40.8%. Past results do not predict the next one.
How much does EVGN move around earnings?
Over its last 5 reports the stock moved an average of 6.8% (absolute, from the close before the report day to the close after it), and finished higher 1 of 5 times.
Did Evogene beat earnings estimates last quarter?
Evogene last reported on Aug 18, 2026: EPS of -$0.13 against an estimate of -$0.27 (+51.8% surprise), a beat.
How much does EVGN usually move in a day?
On a normal trading day the ATLAS model puts EVGN’s one-day range at about ±4.1%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 19, 2026
Educational information, not investment advice. Disclaimer